-
1
-
-
8644252665
-
Prevalence and rate of diagnosis of allergic rhinitis in Europe
-
Bauchau V, Durham SR (2004) Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 24(5):758-764
-
(2004)
Eur Respir J
, vol.24
, Issue.5
, pp. 758-764
-
-
Bauchau, V.1
Durham, S.R.2
-
2
-
-
40549093007
-
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
-
Bousquet J, Khaltaev N, Cruz AA et al (2008) Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(Suppl 86):8-160
-
(2008)
Allergy
, vol.63
, Issue.SUPPL. 86
, pp. 8-160
-
-
Bousquet, J.1
Khaltaev, N.2
Cruz, A.A.3
-
3
-
-
84877664877
-
Allergies to antibiotic drugs: Their importance in otorhinolaryngology
-
Klimek L, Aderhold C, Sperl A (2013) Allergies to antibiotic drugs: their importance in otorhinolaryngology. HNO 61(5):409-415
-
(2013)
HNO
, vol.61
, Issue.5
, pp. 409-415
-
-
Klimek, L.1
Aderhold, C.2
Sperl, A.3
-
4
-
-
84874790341
-
Local (exclusive IgE production in the nasal mucosa. Evidence for local allergic rhinitis
-
Klimek L, Bernus L von, Pfaar O (2013) Local (exclusive IgE production in the nasal mucosa. Evidence for local allergic rhinitis. HNO 61(3):217-223
-
(2013)
HNO
, vol.61
, Issue.3
, pp. 217-223
-
-
Klimek, L.1
Von Bernus, L.2
Pfaar, O.3
-
5
-
-
84870743366
-
Management of anaphylaxis. Part 2: Treatment and emergency equipment
-
Klimek L, Goebel U, Glowania A (2012) Management of anaphylaxis. Part 2: Treatment and emergency equipment. HNO 60(12):1103-1113
-
(2012)
HNO
, vol.60
, Issue.12
, pp. 1103-1113
-
-
Klimek, L.1
Goebel, U.2
Glowania, A.3
-
6
-
-
84857054232
-
German Society of Otorhinolaryngology, Head and Neck Surgery (2012) Rhinosinusitis guidelines - unabridged version: S2 guidelines from the German Society of Otorhinolaryngology
-
Stuck BA, Bachert C, Federspil P et al; German Society of Otorhinolaryngology, Head and Neck Surgery (2012) Rhinosinusitis guidelines - unabridged version: S2 guidelines from the German Society of Otorhinolaryngology, Head and Neck Surgery. HNO 60(2):141-162
-
Head and Neck Surgery. HNO
, vol.60
, Issue.2
, pp. 141-162
-
-
Stuck, B.A.1
Bachert, C.2
Federspil, P.3
-
7
-
-
74349102366
-
Specific immunotherapy with depigmented allergoids
-
Klimek L, Thron C, Pfaar O (2010) Specific immunotherapy with depigmented allergoids. HNO 58(1):51-56
-
(2010)
HNO
, vol.58
, Issue.1
, pp. 51-56
-
-
Klimek, L.1
Thron, C.2
Pfaar, O.3
-
8
-
-
70449523076
-
Cluster immunotherapy of persistent allergic rhinoconjunctivitis. Safety aspects of induction therapy with mite depot allergen preparations
-
Pfaar O, Mösges R, Hörmann K, Klimek L (2009) Cluster immunotherapy of persistent allergic rhinoconjunctivitis. Safety aspects of induction therapy with mite depot allergen preparations. HNO 57(11):1099-1105
-
(2009)
HNO
, vol.57
, Issue.11
, pp. 1099-1105
-
-
Pfaar, O.1
Mösges, R.2
Hörmann, K.3
Klimek, L.4
-
10
-
-
84878812729
-
Evidence-based treatment options for allergic diseases in otolaryngology: An update
-
Klimek L, Sperl A (2013) Evidence-based treatment options for allergic diseases in otolaryngology: an update. HNO 61(6):525-538
-
(2013)
HNO
, vol.61
, Issue.6
, pp. 525-538
-
-
Klimek, L.1
Sperl, A.2
-
11
-
-
34047132671
-
Recombinant allergens for immunotherapy
-
Valenta R, Niederberger V (2007) Recombinant allergens for immunotherapy. J Allergy Clin Immunol 119(4):826-830
-
(2007)
J Allergy Clin Immunol
, vol.119
, Issue.4
, pp. 826-830
-
-
Valenta, R.1
Niederberger, V.2
-
12
-
-
34047180982
-
Update on the current status of peptide immunotherapy
-
Larche M (2007) Update on the current status of peptide immunotherapy. J Allergy Clin Immunol 119(4):906-909
-
(2007)
J Allergy Clin Immunol
, vol.119
, Issue.4
, pp. 906-909
-
-
Larche, M.1
-
13
-
-
56649120612
-
Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial
-
Senti G, Prinz Vavricka BM, Erdmann I et al (2008) Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci USA 105(46):17908-17912
-
(2008)
Proc Natl Acad Sci USA
, vol.105
, Issue.46
, pp. 17908-17912
-
-
Senti, G.1
Prinz Vavricka, B.M.2
Erdmann, I.3
-
14
-
-
84878303560
-
Immunotherapy of allergic rhinitis: New therapeutic opportunities with virus-like particles filled with CpG motifs
-
Klimek L, Schendzielorz P, Mueller P et al (2013) Immunotherapy of allergic rhinitis: new therapeutic opportunities with virus-like particles filled with CpG motifs. Am J Rhinol Allergy 27(3):206-212
-
(2013)
Am J Rhinol Allergy
, vol.27
, Issue.3
, pp. 206-212
-
-
Klimek, L.1
Schendzielorz, P.2
Mueller, P.3
-
15
-
-
80051794923
-
Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: A phase IIb study
-
Klimek L, Willers J, Hammann-Haenni A et al (2011) Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study. Clin Exp Allergy 41(9):1305-1312
-
(2011)
Clin Exp Allergy
, vol.41
, Issue.9
, pp. 1305-1312
-
-
Klimek, L.1
Willers, J.2
Hammann-Haenni, A.3
-
16
-
-
45749103230
-
The coming of age of virus-like particle vaccines
-
Jennings GT, Bachmann MF (2008) The coming of age of virus-like particle vaccines. Biol Chem 389(5):521-536
-
(2008)
Biol Chem
, vol.389
, Issue.5
, pp. 521-536
-
-
Jennings, G.T.1
Bachmann, M.F.2
-
17
-
-
84885647174
-
Immunologische Grundlagen der allergenspezifischen Immuntherapie
-
Blaser K (2009) Immunologische Grundlagen der allergenspezifischen Immuntherapie. Atemw-Lungenkrkh 35:201-222
-
(2009)
Atemw-Lungenkrkh
, vol.35
, pp. 201-222
-
-
Blaser, K.1
-
18
-
-
84864390532
-
Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 1: Pathophysiology, molecular basis
-
Klimek L, Högger P, Pfaar O (2012) Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 1: Pathophysiology, molecular basis. HNO 60(7):611-617
-
(2012)
HNO
, vol.60
, Issue.7
, pp. 611-617
-
-
Klimek, L.1
Högger, P.2
Pfaar, O.3
-
19
-
-
84865421252
-
Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application
-
Bernus L von, Högger P, Pfaar O, Klimek L (2012) Mechanism of action of nasal glucocorticosteroids in the treatment of allergic rhinitis. Part 2: Practical aspects of application. HNO 60(8):700-706
-
(2012)
HNO
, vol.60
, Issue.8
, pp. 700-706
-
-
von Bernus, L.1
Högger, P.2
Pfaar, O.3
Klimek, L.4
-
20
-
-
27644585757
-
T regulatory cells in allergy: Novel concepts in the pathogenesis, prevention, and treatment of allergic diseases
-
(quiz 969)
-
Akdis M, Blaser K, Akdis CA (2005) T regulatory cells in allergy: novel concepts in the pathogenesis, prevention, and treatment of allergic diseases. J Allergy Clin Immunol 116(5):961-968 (quiz 969)
-
(2005)
J Allergy Clin Immunol
, vol.116
, Issue.5
, pp. 961-968
-
-
Akdis, M.1
Blaser, K.2
Akdis, C.A.3
-
21
-
-
33745117912
-
Mechanisms of allergen specific immunotherapy - T-cell tolerance and more
-
Jutel M, Akdis M, Blaser K, Akdis CA (2006) Mechanisms of allergen specific immunotherapy - T-cell tolerance and more. Allergy 61(7):796-807
-
(2006)
Allergy
, vol.61
, Issue.7
, pp. 796-807
-
-
Jutel, M.1
Akdis, M.2
Blaser, K.3
Akdis, C.A.4
-
23
-
-
0027764291
-
The influence of antigen organisation on B cell responsiveness
-
Bachmann MF, Rohrer UH, Kundig TM et al. (1993) The influence of antigen organisation on B cell responsiveness. Science 262(5138):1448-1451
-
(1993)
Science
, vol.262
, Issue.5138
, pp. 1448-1451
-
-
Bachmann, M.F.1
Rohrer, U.H.2
Kundig, T.M.3
-
24
-
-
33749436870
-
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis
-
Creticos PS, Schroeder JT, Hamilton RG et al (2006) Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 355(14):1445-1455
-
(2006)
N Engl J Med
, vol.355
, Issue.14
, pp. 1445-1455
-
-
Creticos, P.S.1
Schroeder, J.T.2
Hamilton, R.G.3
-
25
-
-
33646949257
-
Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults
-
Kundig TM, Senti G, Schnetzler G et al (2006) Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults. J Allergy Clin Immunol 117(6):1470-1476
-
(2006)
J Allergy Clin Immunol
, vol.117
, Issue.6
, pp. 1470-1476
-
-
Kundig, T.M.1
Senti, G.2
Schnetzler, G.3
-
26
-
-
62449179406
-
Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: A phase I/IIa clinical trial
-
Senti G, Johansen P, Haug S et al (2009) Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clin Exp Allergy 39(4):562-570
-
(2009)
Clin Exp Allergy
, vol.39
, Issue.4
, pp. 562-570
-
-
Senti, G.1
Johansen, P.2
Haug, S.3
-
27
-
-
34447119758
-
Eat dirt: CpG DNA and immunomodulation of asthma
-
Kline JN (2007) Eat dirt: CpG DNA and immunomodulation of asthma. Proc Am Thorac Soc 4(3):283-288
-
(2007)
Proc Am Thorac Soc
, vol.4
, Issue.3
, pp. 283-288
-
-
Kline, J.N.1
-
28
-
-
33846438598
-
Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand
-
Ito T, Yang M, Wang Y-H (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 204(1):105-115
-
(2007)
J Exp Med
, vol.204
, Issue.1
, pp. 105-115
-
-
Ito, T.1
Yang, M.2
Wang, Y.-H.3
-
29
-
-
84885580089
-
-
(§§§bitte ergänzen§§§)
-
Manolova et al (§§§bitte ergänzen§§§)
-
-
-
Manolova1
|